Epidemiological Profile and Clinicopathological, Therapeutic, and Prognostic Characteristics of Nasopharyngeal Carcinoma in Northern Morocco
- PMID: 34664512
- PMCID: PMC8529313
- DOI: 10.1177/10732748211050587
Epidemiological Profile and Clinicopathological, Therapeutic, and Prognostic Characteristics of Nasopharyngeal Carcinoma in Northern Morocco
Abstract
Background: Nasopharyngeal carcinoma is a multifactorial disease mainly affecting the Asian and North African populations including Morocco. This study aimed to determine the epidemiological profile of nasopharyngeal carcinoma in Northern Morocco as well as its clinicopathological, therapeutic, and prognostic characteristics.
Methods: 129 patients with nasopharyngeal carcinoma followed at the regional center of oncology of Tangier in the period between April 2017 and July 2019, and diagnosed elsewhere from March 2000 to February 2019, were included in this study. Statistical analysis of the data was realized using Statistical Package for the Social Sciences (SPSS) software.
Results: Nasopharyngeal carcinoma (NPC) represented 5% of all cases with a median age of 50. The most affected age group was 40-54 years (41.1%). Of all patients, 65.9% were men and 34.1% were women with a sex ratio of 1.93 (Male/Female). Undifferentiated nasopharyngeal carcinomas were the most common histological type affecting 96.12% of patients. At diagnosis, the majority of patients (82.2%) had an advanced stage of NPC (III, VIa, b, c) including 5.4% of metastatic cases (IVc). Most cases (86%) had lymph node involvement with cervical mass being the most common clinical presentation. 81.4% of patients received radiotherapy combined with chemotherapy. Among these patients, 54.3% had concurrent radiochemotherapy preceded by induction chemotherapy. The 5-year overall survival (OS) was 86.8% for all patients. It represented 91.3% for early stages, 87.9% for locally advanced stages, and 57.1% for the metastatic stage significantly. The disease-free survival (DFS) at 5 years was 87.6% knowing that relapse occurred in 16 cases.
Conclusions: Nasopharyngeal carcinoma is a particular disease with a late declaration. It is common in Morocco as is the case in other endemic areas with a high prevalence. Patients' survival is significantly influenced by disease staging.
Keywords: Northern Morocco; clinicopathology; epidemiology; nasopharyngeal carcinoma; prognosis; survival; therapy.
Conflict of interest statement
Figures
Similar articles
-
Local and Lymph Node Relapse of Nasopharyngeal Carcinoma: A Single-Center Experience.Ear Nose Throat J. 2021 Sep;100(5_suppl):795S-800S. doi: 10.1177/0145561320908955. Epub 2020 Mar 6. Ear Nose Throat J. 2021. PMID: 32141322
-
[Therapeutic outcomes of nasopharyngeal carcinomas: a single-center study conducted at the Fattouma Bourguiba University Hospital in Monastir, Tunisia].Pan Afr Med J. 2021 Feb 9;38:143. doi: 10.11604/pamj.2021.38.143.15510. eCollection 2021. Pan Afr Med J. 2021. PMID: 33912313 Free PMC article. French.
-
Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.BMC Cancer. 2020 Jul 17;20(1):667. doi: 10.1186/s12885-020-07146-z. BMC Cancer. 2020. PMID: 32680466 Free PMC article.
-
Atypical metastasis of nasopharyngeal cancer: noncontiguous spread to the ipsilateral ear.Clin Imaging. 2021 Apr;72:70-74. doi: 10.1016/j.clinimag.2020.11.029. Epub 2020 Nov 14. Clin Imaging. 2021. PMID: 33217673 Review.
-
Pattern of metastasis of head and neck cancer in Nigeria: A 10 year review.Niger J Clin Pract. 2023 Jul;26(7):847-855. doi: 10.4103/njcp.njcp_1385_21. Niger J Clin Pract. 2023. PMID: 37635566 Review.
Cited by
-
The Nasopharyngeal Carcinoma and Its Effect on the Infectious Eye Disease: A Nationwide Cohort Study.Cancers (Basel). 2022 Nov 23;14(23):5745. doi: 10.3390/cancers14235745. Cancers (Basel). 2022. PMID: 36497227 Free PMC article.
-
Prevalence of locoregional recurrence and survival post-treatment of head and neck cancers in Africa: a systematic review and meta-analysis.EClinicalMedicine. 2023 Apr 13;59:101964. doi: 10.1016/j.eclinm.2023.101964. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37125401 Free PMC article.
-
Nasopharyngeal cancer risk assessment by country or region worldwide from 1990 to 2019.BMC Public Health. 2024 Jul 18;24(1):1931. doi: 10.1186/s12889-024-19228-9. BMC Public Health. 2024. PMID: 39026191 Free PMC article.
-
Treatment initiation and completion among head and neck squamous cell carcinoma patients in Tanzania.BMC Res Notes. 2024 Dec 23;17(1):380. doi: 10.1186/s13104-024-07045-7. BMC Res Notes. 2024. PMID: 39716326 Free PMC article.
-
Ethno-geographic distribution and histopathological classification of nasopharyngeal carcinoma in a single center in Nepal.PLoS One. 2024 May 31;19(5):e0304371. doi: 10.1371/journal.pone.0304371. eCollection 2024. PLoS One. 2024. PMID: 38820402 Free PMC article.
References
-
- Hermans R, ed. Neoplasms of the Nasopharynx In: Head and neck cancer imaging. Berlin/Heidelberg, Germany: Springer-Verlag; 2006:143-162.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous